ATLAS project – Asian Clinical Trials Network for Cancers Project shared on LinkedIn:
“On July 10, National Cancer Center Hospital Japan (NCCH) signed a Memorandum of Understanding (MoU) with the National Cancer Centre Singapore (NCCS), marking another important step in strengthening collaboration between the two institutions.
As the lead institution of the ATLAS Project (Asian Clinical Trials Network for Cancers), NCCH is committed to advancing multinational clinical trials and accelerating access to innovative cancer treatments across Asia.
This MoU will further advance collaboration between NCCH and NCCS, particularly in clinical research, education, and clinical trials, with the aim of improving cancer care across Asia.
To commemorate this important milestone, Dr. Yasuyuki Seto, Director of NCCH, and Prof. Lim Soon Thye, Chief Executive Officer of NCCS, exchanged a handshake following the signing ceremony, symbolizing the shared commitment of both institutions to advancing cancer research and patient care across Asia.
We look forward to continuing our collaboration with NCCS and our partners across Asia through the ATLAS Project to accelerate innovation and improve outcomes for patients.”
